Clinical Relevance and Role of Neuronal AT 1 Receptors in ADAM17-Mediated ACE2 Shedding in Neurogenic Hypertension
Open accessThe DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.
Abstract
Rationale: Neurogenic hypertension is characterized by an increase in sympathetic activity and often resistance to drug treatments. We previously reported that it is also associated with a reduction of angiotensin-converting enzyme type 2 (ACE2) and an increase in a disintegrin and metalloprotease 17 (ADAM17) activity in experimental hypertension. In addition, while multiple cells within the central nervous system have been involved in the development of neurogenic hypertension, the contribution of ADAM17 has not been investigated. Objective: To assess the clinical relevance of this ADAM17-mediated ACE2 shedding in hypertensive patients and further identify the cell types and signaling pathways involved in this process. Methods and Results: Using a mass spectrometry-based assay, we identified ACE2 as the main enzyme converting angiotensin II into angiotensin-(1–7) in human cerebrospinal fluid. We also observed an increase in ACE2 activity in the cerebrospinal fluid of hypertensive patients, which was correlated with systolic blood pressure. Moreover, the increased level of tumor necrosis factor-α in those cerebrospinal fluid samples confirmed that ADAM17 was upregulated in the brain of hypertensive patients. To further assess the interaction between brain renin–angiotensin system and ADAM17, we generated mice lacking angiotensin II type 1 receptors specifically on neurons. Our data reveal that despite expression on astrocytes and other cells types in the brain, ADAM17 upregulation during deoxycorticosterone acetate–salt hypertension occurs selectively on neurons, and neuronal angiotensin II type 1 receptors are indispensable to this process. Mechanistically, reactive oxygen species and extracellular signal-regulated kinase were found to mediate ADAM17 activation. Conclusions: Our data demonstrate that angiotensin II type 1 receptors promote ADAM17-mediated ACE2 shedding in the brain of hypertensive patients, leading to a loss in compensatory activity during neurogenic hypertension.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Donoghue, M., Hsieh, F., Baronas, E., Godbout, K., Gosselin, M., Stagliano, N., Donovan, M., Woolf, B., Robison, K., Jeyaseelan, R., et al. (2000) · Circulation Research · doi:10.1161/01.res.87.5.e1 · Cited by 2,485
Measuring reactive oxygen and nitrogen species with fluorescent probes: challenges and limitations
Kalyanaraman, B., Darley-Usmar, V., Davies, K. J. A., Dennery, P. A., Forman, H. J., Grisham, M. B., Mann, G. E., Moore, K., Roberts, L. J., & Ischiropoulos, H. (2012) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2011.09.030 · Cited by 1,774 · cited 1×
“Apart from superoxide-mediated oxidation to 2-hydroxyethidium, DHE can also undergo unspecific oxidation via ONOO or OH into ethidium.(47) Because the difference in their fluorescence spectra is small, analytical methods, like high-performance liquid chromatography and mass spectrometry, should be applied to verify th…”
Lambert, D. W., Yarski, M., Warner, F. J., Thornhill, P., Parkin, E. T., Smith, A. I., Hooper, N. M., & Turner, A. J. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m505111200 · Cited by 694 · cited 3×
“discovered by the observation of increased sACE2 levels in the culture medium of cells transfected with ADAM17.(20) ACE2 is”
InfluentialADAM17: a molecular switch to control inflammation and tissue regeneration
Scheller, J., Chalaris, A., Garbers, C., & Rose-John, S. (2011) · Trends in Immunology · doi:10.1016/j.it.2011.05.005 · Cited by 526
Li, Y., & Trush, M. A. (1998) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1998.9729 · Cited by 478 · cited 1×
“ubiquinone oxidoreductase, NADPH oxidases, and NADPH cytochrome P450 oxidoreductase.(44,45) It is well documented”
Doobay, M. F., Talman, L. S., Obr, T. D., Tian, X., Davisson, R. L., & Lazartigues, E. (2007) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00292.2006 · Cited by 406
Self-citationBrain Microglial Cytokines in Neurogenic Hypertension
Shi, P., Diez-Freire, C., Jun, J. Y., Qi, Y., Katovich, M. J., Li, Q., Sriramula, S., Francis, J., Sumners, C., & Raizada, M. K. (2010) · Hypertension · doi:10.1161/hypertensionaha.110.150409 · Cited by 386
Self-citationEctodomain shedding of angiotensin converting enzyme 2 in human airway epithelia
Jia, H. P., Look, D. C., Tan, P., Shi, L., Hickey, M., Gakhar, L., Chappell, M. C., Wohlford-Lenane, C., & McCray, P. B. (2009) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00071.2009 · Cited by 329
Patel, V. B., Clarke, N., Wang, Z., Fan, D., Parajuli, N., Basu, R., Putko, B., Kassiri, Z., Turner, A. J., & Oudit, G. Y. (2014) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2013.11.017 · Cited by 321
Marvar, P. J., Thabet, S. R., Guzik, T. J., Lob, H. E., McCann, L. A., Weyand, C., Gordon, F. J., & Harrison, D. G. (2010) · Circulation Research · doi:10.1161/circresaha.110.217299 · Cited by 317 · cited 1×
“Wild-type mice were infused with NE, a peripherally acting vasoconstrictor, at a dose previously reported to produce a sustained hypertension.(13) The 14-day infusion of NE drove significant cardiac and renal hypertrophy (Figure 5A and 5B), supporting a BP increase after NE treatment in these mice.”
Deshotels, M. R., Xia, H., Sriramula, S., Lazartigues, E., & Filipeanu, C. M. (2014) · Hypertension · doi:10.1161/hypertensionaha.114.03743 · Cited by 264 · cited 1×
“Among the mechanisms leading to impaired ACE2 activity in hypertension, we previously reported ADAM17-mediated shedding and AT 1 R-dependent internalization.(5,6) While there are no data available for the latter, in humans, elevated sACE2 has been reported in the periphery in heart failure,(23,24) hypertension,(24) se…”
Self-citationXu, P., & Derynck, R. (2010) · Molecular Cell · doi:10.1016/j.molcel.2010.01.034 · Cited by 257
Detection of Soluble Angiotensin-Converting Enzyme 2 in Heart Failure
Epelman, S., Tang, W. H. W., Chen, S. Y., Van Lente, F., Francis, G. S., & Sen, S. (2008) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2008.02.088 · Cited by 250
Soond, S. M., Everson, B., Riches, D. W. H., & Murphy, G. (2005) · Journal of Cell Science · doi:10.1242/jcs.02357 · Cited by 234
Ishizaka, N., Griendling, K. K., Lassègue, B., & Alexander, R. W. (1998) · Hypertension · doi:10.1161/01.hyp.32.3.459 · Cited by 225 · cited 1×
“tion, and these rafts play a critical role for AT 1 R-mediated signal transduction.(33,34) Altogether, it is conceivable that on RAS over-”
Neuroprotective Effects of Angiotensin Receptor Blockers
Villapol, S., & Saavedra, J. M. (2015) · American Journal of Hypertension · doi:10.1093/ajh/hpu197 · Cited by 212 · cited 1×
“cell-specific expression of AT 1a R, in the CNS, has been shown to contribute to neurogenic hypertension(10,27,28) and other ailments.(29) Because AT 1a R and ADAM17 coexist on various cell types, including endothelial cells,(30) vascular smooth muscle cells,(31) glial cells, and neurons,(32) the contribution of cell-…”
Diphenyleneiodonium Inhibits the Cell Redox Metabolism and Induces Oxidative Stress
Riganti, C., Gazzano, E., Polimeni, M., Costamagna, C., Bosia, A., & Ghigo, D. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m406314200 · Cited by 200 · cited 1×
“ubiquinone oxidoreductase, NADPH oxidases, and NADPH cytochrome P450 oxidoreductase.(44,45) It is well documented”
Angiotensin II sustains brain inflammation in mice via TGF-β
Lanz, T. V., Ding, Z., Ho, P. P., Luo, J., Agrawal, A. N., Srinagesh, H., Axtell, R., Zhang, H., Platten, M., Wyss-Coray, T., et al. (2010) · Journal of Clinical Investigation · doi:10.1172/jci41709 · Cited by 198
DOCA-Salt Hypertension: an Update
Basting, T. M., & Lazartigues, E. D. (2017) · Current Hypertension Reports · doi:10.1007/s11906-017-0731-4 · Cited by 189 · cited 4×
“neurogenic component and typical features, including salt sensitivity, low plasma renin levels, and an overactive brain RAS.(11)”
InfluentialSelf-citationInvolvement of Bone Marrow Cells and Neuroinflammation in Hypertension
Santisteban, M. M., Ahmari, N., Carvajal, J. M., Zingler, M. B., Qi, Y., Kim, S., Joseph, J., Garcia-Pereira, F., Johnson, R. D., Shenoy, V., et al. (2015) · Circulation Research · doi:10.1161/circresaha.117.305853 · Cited by 181
Yamazato, M., Yamazato, Y., Sun, C., Diez-Freire, C., & Raizada, M. K. (2007) · Hypertension · doi:10.1161/01.hyp.0000259942.38108.20 · Cited by 180 · cited 1×
“Regardless of the enzyme’s compensatory effects, during neurogenic hypertension, brain expression and activity of ACE2 are found to be compromised.(3,4) Previous work has shown that central ACE2 is downregulated in several Translational Research”
Xia, H., Sriramula, S., Chhabra, K. H., & Lazartigues, E. (2013) · Circulation Research · doi:10.1161/circresaha.113.301811 · Cited by 173
Self-citationAngiotensin-Converting Enzyme 2: Central Regulator for Cardiovascular Function
Xia, H., & Lazartigues, E. (2010) · Current Hypertension Reports · doi:10.1007/s11906-010-0105-7 · Cited by 148 · cited 1×
“Our group previously reported that ACE2 is expressed throughout the brain, including in regions involved in central regulation of BP, such as the subfornical organ, paraventricular nucleus of hypothalamus, nucleus of the solitary tract, and rostral ventrolateral medulla.(1,2) Regardless of the enzyme’s compensatory ef…”
Self-citationWeskamp, G., Mendelson, K., Swendeman, S., Le Gall, S., Ma, Y., Lyman, S., Hinoki, A., Eguchi, S., Guaiquil, V., Horiuchi, K., et al. (2010) · Circulation Research · doi:10.1161/circresaha.109.207415 · Cited by 146
Microglia Participate in Neurogenic Regulation of Hypertension
Shen, X. Z., Li, Y., Li, L., Shah, K. H., Bernstein, K. E., Lyden, P., & Shi, P. (2015) · Hypertension · doi:10.1161/hypertensionaha.115.05333 · Cited by 146
Ohtsu, H., Dempsey, P. J., Frank, G. D., Brailoiu, E., Higuchi, S., Suzuki, H., Nakashima, H., Eguchi, K., & Eguchi, S. (2006) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000236203.90331.d0 · Cited by 140
ACE2 alterations in kidney disease
Soler, M. J., Wysocki, J. A., & BATLLE, D. C. (2013) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gft320 · Cited by 135
Rapid and Specific Measurements of Superoxide Using Fluorescence Spectroscopy
Nazarewicz, R. R., Bikineyeva, A., & Dikalov, S. I. (2013) · SLAS Discovery · doi:10.1177/1087057112468765 · Cited by 127 · cited 1×
“Because the difference in their fluorescence spectra is small, analytical methods, like high-performance liquid chromatography and mass spectrometry, should be applied to verify the specific superoxide signals.(48) Electron paramagnetic resonance spectroscopy can also be used for ROS detection.”
Insulin treatment attenuates renal ADAM17 and ACE2 shedding in diabetic Akita mice
Salem, E., Grobe, N., & Elased, K. M. (2014) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00516.2013 · Cited by 120
Biancardi, V. C., Stranahan, A. M., Krause, E. G., de Kloet, A. D., & Stern, J. E. (2016) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00247.2015 · Cited by 115
Stern, J. E., Son, S. J., Biancardi, V. C., Zheng, H., Sharma, N. M., & Patel, K. P. (2016) · Hypertension · doi:10.1161/hypertensionaha.116.07747 · Cited by 109
Xia, H., Feng, Y., Obr, T. D., Hickman, P. J., & Lazartigues, E. (2009) · Hypertension · doi:10.1161/hypertensionaha.108.123844 · Cited by 105 · cited 1×
“Regardless of the enzyme’s compensatory effects, during neurogenic hypertension, brain expression and activity of ACE2 are found to be compromised.(3,4) Previous work has shown that central ACE2 is downregulated in several Translational Research”
Self-citationLi, W., Sullivan, M. N., Zhang, S., Worker, C. J., Xiong, Z., Speth, R. C., & Feng, Y. (2015) · Hypertension · doi:10.1161/hypertensionaha.114.04458 · Cited by 101
Kohno, M. (2010) · Journal of Clinical Biochemistry and Nutrition · doi:10.3164/jcbn.10-13r · Cited by 101 · cited 1×
“Electron paramagnetic resonance spectroscopy can also be used for ROS detection.(49) (3) The present data highlight significant variability within our ADAM17 activity assay, so it is not suitable for comparisons between experiments.”
Neuron-Specific (Pro)renin Receptor Knockout Prevents the Development of Salt-Sensitive Hypertension
Li, W., Peng, H., Mehaffey, E. P., Kimball, C. D., Grobe, J. L., van Gool, J. M. G., Sullivan, M. N., Earley, S., Danser, A. H. J., Ichihara, A., et al. (2014) · Hypertension · doi:10.1161/hypertensionaha.113.02041 · Cited by 97
Wang, X., Oka, T., Chow, F. L., Cooper, S., Odenbach, J., Lopaschuk, G. D., Kassiri, Z., & Fernández-Patrón, C. (2009) · Hypertension · doi:10.1161/hypertensionaha.108.127670 · Cited by 96 · cited 7×
“ACE2 transforms Ang II into angiotensin-(1–7) [Ang-(1–7)], thus, turning the vasoconstrictor into a vasodilator peptide, promoting nitric oxide release, reducing sympathetic outflow, increasing baroreflex sensitivity, and ultimately reducing high BP.”
InfluentialKatalin, Ú., Fagyas, M., Siket, I. M., Kertész, A., Csanádi, Z., Sándorfi, G., Clemens, M., Fedor, R., Papp, Z., Edes, I. F., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0087845 · Cited by 92
ADAM17 upregulation in human renal disease: a role in modulating TGF-α availability?
Melenhorst, W. B. W. H., Visser, L., Timmer, A., van den Heuvel, M. C., Stegeman, C. A., & van Goor, H. (2009) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.90610.2008 · Cited by 84
Antioxidant-based therapies for angiotensin II-associated cardiovascular diseases
Rosenbaugh, E. G., Savalia, K. K., Manickam, D. S., & Zimmerman, M. C. (2013) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00395.2012 · Cited by 79
Sriramula, S., Xia, H., Xu, P., & Lazartigues, E. D. (2014) · Hypertension · doi:10.1161/hypertensionaha.114.04691 · Cited by 77
Self-citationMicrovesicles in the brain: Biomarker, messenger or mediator?
Porro, C., Trotta, T., & Panaro, M. A. (2015) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2015.09.006 · Cited by 77 · cited 1×
“receptors, can be formed by Ang II and induce membrane trafficking in hypothalamic cells.(42,43) Although not the focus of”
Karamyan, V. T., & Speth, R. C. (2007) · Regulatory Peptides · doi:10.1016/j.regpep.2007.03.006 · Cited by 77
A Disintegrin and Metalloprotease 17 in the Cardiovascular and Central Nervous Systems
Xu, J., Mukerjee, S., Silva-Alves, C. R. A., Carvalho‐Galvão, A., Cruz, J. C., Balarini, C. M., Braga, V. A., Lazartigues, E. D., & França-Silva, M. S. (2016) · Frontiers in Physiology · doi:10.3389/fphys.2016.00469 · Cited by 69 · cited 2×
“teases (ADAM) family, is known to cleave a variety of membrane-anchored proteins.(7) We previously demonstrated an”
Self-citationCaveolin-Dependent Angiotensin II Type 1 Receptor Signaling in Vascular Smooth Muscle
Ushio‐Fukai, M., & Alexander, R. W. (2006) · Hypertension · doi:10.1161/01.hyp.0000242907.70697.5d · Cited by 61
TACE/ADAM17 Is Essential for Oligodendrocyte Development and CNS Myelination
Palazuelos, J., Crawford, H. C., Klingener, M., Sun, B., Karelis, J., Raines, E. W., & Aguirre, A. A. (2014) · Journal of Neuroscience · doi:10.1523/jneurosci.1220-14.2014 · Cited by 44
Elliott, K. J., Bourne, A., Takayanagi, T., Takaguri, A., Kobayashi, T., Eguchi, K., & Eguchi, S. (2013) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2013.05.005 · Cited by 39
de Queiroz, T. M., Xia, H., Filipeanu, C. M., Braga, V. A., & Lazartigues, E. D. (2015) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00259.2015 · Cited by 35
Self-citationAdebiyi, A., Soni, H., John, T. A., & Yang, F. (2014) · Experimental Cell Research · doi:10.1016/j.yexcr.2014.03.011 · Cited by 25 · cited 1×
“tion, and these rafts play a critical role for AT 1 R-mediated signal transduction.(33,34) Altogether, it is conceivable that on RAS over-”
Saxena, A., Bachelor, M., Park, Y. H., Carreno, F. R., Nedungadi, T. P., & Cunningham, J. T. (2014) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00224.2014 · Cited by 18 · cited 1×
“receptors, can be formed by Ang II and induce membrane trafficking in hypothalamic cells.(42,43) Although not the focus of”
Cited by
Gheblawi, M., Wang, K., Viveiros, A., Nguyen, Q., Zhong, J.-C., Turner, A. J., Raizada, M. K., Grant, M. B., & Oudit, G. Y. (2020) · Circulation Research · doi:10.1161/circresaha.120.317015 · Cited by 1,882
The pivotal link between ACE2 deficiency and SARS-CoV-2 infection
Verdecchia, P., Cavallini, C., Spanevello, A., & Angeli, F. (2020) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2020.04.037 · Cited by 1,237
“[17] Elevated circulating levels of soluble ACE2 are markers of different disease states characterized by increased activity of the renin-angiotensin system and associated with a worse prognosis.”
Angiotensin II Signal Transduction: An Update on Mechanisms of Physiology and Pathophysiology
Forrester, S. J., Booz, G. W., Sigmund, C. D., Coffman, T. M., Kawai, T., Rizzo, V., Scalia, R., & Eguchi, S. (2018) · Physiological Reviews · doi:10.1152/physrev.00038.2017 · Cited by 1,095
Sama, I. E., Ravera, A., Santema, B. T., van Goor, H., ter Maaten, J. M., Cleland, J. G. F., Rienstra, M., Friedrich, A. W., Samani, N. J., Ng, L. L., et al. (2020) · European Heart Journal · doi:10.1093/eurheartj/ehaa373 · Cited by 460
Danser, A. H. J., Epstein, M., & Batlle, D. (2020) · Hypertension · doi:10.1161/hypertensionaha.120.15082 · Cited by 457
Metadata
- Authors
- Xu, J., Sriramula, S., Xia, H., Moreno-Walton, L., Culicchia, F., Domenig, O., Poglitsch, M., & Lazartigues, E.
- Venue
- Circulation Research
- Published
- 2017-06-23
- Volume
- 121
- Issue
- 1
- Pages
- 43-55
- ISSN
- 0009-7330 (ISSN-L)
- 1524-4571
- OpenAlex
- W2616436626
- Cited by
- 171
- References
- 49
- FWCI
- 12.50
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.